Skip to main content

Table 3

From: Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine

  Loratadine Dissatisfied Segments – Severe Allergic Rhinitis
  Converted to Fexofenadine N = 88 (weighted) Converted to Desloratadine N = 35 (weighted)
Side Effects   
   Sum of Adverse Events1 2.0** 1.35**
Symptom Relief   
   EOD Failure – Nighttime Awakening1 2.93** 1.81**
   EOD Failure – Morning Symptoms1 3.74 3.62
   Onset of Relief2 4.34 4.58
   Coverage Period2 4.37** 5.15**
   Overall Symptom Relief2 4.92 5.34
Overall Satisfaction   
   Continuation Intentions2 5.10 5.41
   Likelihood to Recommend2 4.66 5.32
   Overall Satisfaction with Current Rx2 4.67* 5.37*
   Satisfaction with Rx Change2 4.76 5.27
  1. *p < = .05 **p < = .01 1 Higher number reflects negative medication experience. 2 Higher number reflects positive medication experience.